SKI-606, a Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.
CONCLUSIONS: Our findings suggest that Src is critical in the progression of thyroid cancer, making oral SKI-606 a promising treatment strategy for refractory thyroid cancer.
PMID: 22271876 [PubMed - as supplied by publisher] (Source: Clinical Cancer Research)
Komen official quits over Planned Parenthood
High-ranking official in breast-cancer charity resigns, saying she supported decision to pull Planned Parenthood funding (Source: Health News: CBSNews.com)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div
